Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 14, 1985 - Issue 2
4
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Translation of Human Macrophage Activating Factor (For Glucose Consumption) Mrna in Xenopus Laevis Oocytes

, , , , &
Pages 95-103 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Virmantas Stunžėnas. (2001) Parasite-Host Interaction: A New Point of View on Immune Regulation. Acta Zoologica Lituanica 11:4, pages 405-416.
Read now

Articles from other publishers (3)

Shin‐ichiro Hirose, Shinji Ooki, Masahiro Higuchi & Toshiaki Osawa. (2013) Macrophage Migration Inhibitory Factor (MIF) Produced by a Human T Cell Hybridoma Clone. Microbiology and Immunology 35:3, pages 235-245.
Crossref
Wang Hsuei-Chin, Bernard Beer, Daniela Sassano, Arthur J. Blume & M.Reza Ziai. (1991) Gene expression in Xenopus oocytes. International Journal of Biochemistry 23:3, pages 271-276.
Crossref
Miyamoto Daisei, Nakamura Noriko, Ishii Yoshiyuki, Kobayashi Yoshiro & Osawa Toshiaki. (1987) Establishment of a human T-Cell hybridoma that produces human macrophage activating factor for superoxide production and translation of messenger RNA of the factor in Xenopus Laevis oocyte. Molecular Immunology 24:3, pages 239-245.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.